Financing
Debt Repayments
Northrop Grumman Debt Repayments decreased by 64.9% to $527.00M in Q1 2026 compared to the prior quarter. Year-over-year, this metric declined by 64.9%, from $1.50B to $527.00M. This is a positive signal — lower values indicate better performance for this metric.
Analysis
StatementCash Flow Statement
SectionFinancing
CategoryLeverage
SignalLower is better
VolatilityModerate
First reportedQ1 2013
Last reportedQ1 2026Apr 21, 2026
How to read this metric
A decrease may indicate a focus on capital preservation or refinancing, while a significant increase signals active debt reduction or maturity fulfillment.
Detailed definition
Represents the total cash outflows used to reduce the principal balance of short-term and long-term debt obligations. Th...
Peer comparison
Standard across all capital-intensive industries; peers with high leverage typically show higher repayment activity.
Metric ID:
debt_repaymentHistorical Data
15 periods
| Q2 '21 | Q1 '22 | Q2 '22 | Q3 '22 | Q4 '22 | Q1 '23 | Q2 '23 | Q3 '23 | Q4 '23 | Q1 '24 | Q2 '24 | Q3 '24 | Q4 '24 | Q1 '25 | Q1 '26 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Value | $36.00M | $0.00 | $0.00 | $0.00 | $0.00 | $262.50M | $262.50M | $262.50M | $262.50M | $0.00 | $0.00 | $0.00 | $0.00 | $1.50B | $527.00M |
| QoQ Change | — | -100.0% | — | — | — | — | +0.0% | +0.0% | +0.0% | -100.0% | — | — | — | — | -64.9% |
| YoY Change | — | — | -100.0% | — | — | — | — | — | — | -100.0% | -100.0% | -100.0% | -100.0% | — | -64.9% |
Range$0.00 – $1.50B
CAGR+115.3%
Avg YoY Growth-94.1%
Median YoY Growth-100.0%
Debt Repayments at Other Companies
Frequently Asked Questions
- What is Northrop Grumman's debt repayments?
- Northrop Grumman (NOC) reported debt repayments of $527.00M in Q1 2026.
- How has Northrop Grumman's debt repayments changed year-over-year?
- Northrop Grumman's debt repayments decreased by 64.9% year-over-year, from $1.50B to $527.00M.
- What does debt repayments mean?
- The total amount of cash used to pay down debt principal.